Mechanical heart valve often the safest choice, study says

November 8, 2017, Stanford University Medical Center
Credit: CC0 Public Domain

Mechanical heart valves may be safer in certain cases than valves made of animal tissue and should be used more in heart-valve replacements, especially in younger patients, according to a study by researchers at the Stanford University School of Medicine.

The study also found that unlike what's recommended in the national guidelines, which say patients ages 50 to 70 undergoing aortic or mitral valve replacement should be given a choice of either a mechanical or biological valve, the best choice in fact can hinge on whether the aortic or mitral valve is being replaced.

The study shows that for patients undergoing mitral valve replacement, a mechanical valve is actually beneficial until the age of 70. On the other hand, for patients undergoing aortic valve replacement, the benefit of implanting mechanical valves ceased after the age of 55.

"This has potential to significantly impact the current national practice guidelines," said Joseph Woo, MD, professor and chair of cardiothoracic at Stanford, who routinely performs these surgeries. "While our preference is always to repair heart valves whenever possible, there are certain disease processes which necessitate valve replacement. For these patients, given the study's new and unexpected findings, I am already pondering, 'How am I going to counsel my patients today?' The advice may not be the same as the current national guideline recommendations."

The study will be published Nov. 8 in The New England Journal of Medicine. Woo is the senior author. Postdoctoral scholar Andrew Goldstone, MD, PhD, is the lead author.

Most patients who need open-heart surgery to remove a diseased heart valve face complicated conversations with their heart surgeons about whether to use a natural-tissue or mechanical valve as a replacement.

Mechanical valves can last a lifetime, but they come with increased risks of blood clotting and bleeding and a lifetime of having to take the blood-thinning medication warfarin. Biological valves, which are most often made from pig or cow tissue, don't increase the risk of bleeding or clotting, but they wear out within about 10 to 15 years, making a second surgery likely.

'A perplexing question'

"This is a perplexing question and comes up for me every single day with patients," said Woo, who holds the Norman E. Shumway Professorship. The decision has been made difficult by the lack of sufficient scientific evidence to back up either choice, he said. Instead, it becomes something of an educated-guessing game based on the age of a patient, comorbidities, a patient's personal preferences and the somewhat vague national guidelines published by the American Heart Association and American College of Cardiology. For those younger than 50, a mechanical valve is currently recommended, and for those older than 70, a biologic tissue valve is recommended, Woo said.

However, the associations' guidelines don't distinguish between whether the mitral or aortic valve is being replaced.

"If you think about this just in terms of age, the older you are, the less likely that you will outlive the durability of a biological valve," Woo said. He added that surgeons have noted in recent years a trend toward younger patients choosing biological valves, primarily because they don't want to deal with a lifetime of taking blood thinners and with the accompanying dietary restrictions and routine blood testing necessitated by a mechanical valve.

The American Heart Association estimates that 5 million Americans suffer from heart-valve disease, which forces the heart to work harder to pump blood and can lead to heart failure and sudden death. The disease can be present at birth or result from infections, heart attacks or other heart conditions.

When a valve becomes so diseased that it impedes the delivery of blood to the body, open-heart surgery to replace the valve with a new one generally is recommended. Each year, more than 50,000 people in the United States undergo either aortic- or mitral-valve replacement surgery, according to the study.

To compare the long-term risks and benefits of mechanical versus biological , researchers examined rates of mortality, stroke, bleeding and reoperation in patients who underwent heart-valve surgery at 142 hospitals in California between 1996 and 2013. Patient records were obtained from the California Office of Statewide Health Planning and Development databases.

Researchers examined the records of 9,942 patients who underwent aortic-valve replacement and 15,503 patients who underwent mitral-valve replacement during the study period.

"Our research likely contains the largest number of patients ever studied to examine this issue," Woo said.

A stark difference

Results showed a stark difference in health benefits depending on which valve was being replaced, Woo said. The long-term mortality benefit associated with a mechanical valve compared with a biological valve persisted until age 70 in patients undergoing mitral-valve replacement, the study found. For those undergoing , this benefit persisted only until age 55.

"This study will definitely change the information that I give my patients," said Jennifer Lawton, MD, professor of surgery and chief of the Johns Hopkins University Division of Cardiac Surgery, who was not involved with the study. Lawton, like Woo, faces the same daily discussion with her patients about which valve to choose. "The benefit of this study is that it looks at so many patients over a period of time," she said. "Up until now, there have only been small studies on which the guidelines are based."

The current national guidelines are based on data from studies that are not only small, but which examined the use of now-obsolete valves that were implanted more than 30 years ago, the study said.

"Over the last 15 or 20 years around the world, there has been a dramatic shift in the increased use of bioprosthetic valves," said Michael Argenziano, MD, professor of surgery and chief of adult cardiac surgery at Columbia University. "This is the first paper to provide solid evidence that maybe we have been moving too quickly away from the ." Argenziano was not involved in the study.

Sharing the results of this study with patients is particularly urgent right now because of this growing trend toward younger patients choosing biological valves, Woo said.

"People just don't want to take blood thinners," Woo said, adding that patients are also hoping that experimental transcatheter technology, which could allow without the need for open heart surgery, will be available for them in 10 or 15 years when they would potentially need another surgery.

Lawton agreed that she's seen a similar trend and believes it's probably occurring across the United States and the world.

"People don't want to change their lifestyles, in particular women who want to have children and don't want to take blood thinners," she said.

This new study should give both and their surgeons valuable new information, Woo said.

"For most heart surgeons who have to face this conversation every single day, this choice is very much on our minds," Woo said. "For many surgeons throughout the country and beyond, this study could have a major impact."

Explore further: Study shows minimally invasive valve replacements hold up well after five years

Related Stories

Study shows minimally invasive valve replacements hold up well after five years

September 27, 2017
A minimally invasive procedure used to replace heart valves without open heart surgery appears to provide a durable remedy for people with a life-threatening form of heart disease in which the aortic valve opening narrows, ...

Fewer infections in mechanical heart valves

July 19, 2017
Infections in surgically implanted heart valves are more common in patients who have been given a biological prosthetic valve than in those with a mechanical one, a study from Karolinska Institutet published today in the ...

Study shows low mortality and stroke risks for minimally invasive aortic valve replacements

October 5, 2017
An analysis of more than 1,000 minimally invasive aortic valve replacements and more than 400 additional associated procedures over a five-and-a-half year period performed by Dr. Joseph Lamelas, professor and associate chief ...

Heart valves made from tissue rather than metal may be better for middle-aged patients

January 12, 2016
Patients between the ages of 40 and 70 who undergo aortic valve replacement (AVR) may fare better with tissue-based valves rather than metal-based valves, according to a review article posted online today by The Annals of ...

Successful transcatheter treatment of severe cardiac failure

September 11, 2017
The Cardiovascular Surgery Group at Osaka University performed a transcatheter mitral valve implantation in dysfunctional artificial valves in severe cardiac failure patients with prosthetic valve dysfunction, which was previously ...

Mechanical heart valve prosthesis superior to biological

November 12, 2015
A mechanical valve prosthesis has a better survival record than a biological valve prosthesis, according to a large registry study from Sweden's Karolinska Institutet. The finding, which is published in the European Heart ...

Recommended for you

New China and US studies back use of pulse oximeters for assessing blood pressure

November 21, 2018
Fast and easy blood pressure monitoring could soon be at your fingertips—literally—thanks to new University of British Columbia research that showed BP can be assessed by a fingertip oximeter, a tool not generally used ...

Gut protein mutations shield against spikes in glucose

November 20, 2018
Why is it that, despite consuming the same number of calories, sodium and sugar, some people face little risk of diabetes or obesity while others are at higher risk? A new study by investigators at Brigham and Women's Hospital ...

Proteins cooperate to break up energy structures in oxygen starved heart cells

November 19, 2018
During a heart attack, the supply of oxygen to heart cells is decreased. This reduced oxygen level, called hypoxia, causes the cell's powerhouses, the mitochondria, to fragment, impairing cell function and leading to heart ...

Bullying and violence at work increases the risk of cardiovascular disease

November 19, 2018
People who are bullied at work or experience violence at work are at higher risk of heart and brain blood vessel problems, including heart attacks and stroke, according to the largest prospective study to investigate the ...

Genetic analysis links obesity with diabetes, coronary artery disease

November 16, 2018
A Cleveland Clinic genetic analysis has found that obesity itself, not just the adverse health effects associated with it, significantly increases the risk of Type 2 diabetes and coronary artery disease. The paper was published ...

Non-coding genetic variant could improve key vascular functions

November 15, 2018
Atherosclerotic disease, the slow and silent hardening and narrowing of the arteries, is a leading cause of mortality worldwide. It is responsible for more than 15 million deaths each year, including an estimated 610,000 ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.